FR2338285B1 - - Google Patents

Info

Publication number
FR2338285B1
FR2338285B1 FR7701034A FR7701034A FR2338285B1 FR 2338285 B1 FR2338285 B1 FR 2338285B1 FR 7701034 A FR7701034 A FR 7701034A FR 7701034 A FR7701034 A FR 7701034A FR 2338285 B1 FR2338285 B1 FR 2338285B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7701034A
Other languages
French (fr)
Other versions
FR2338285A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of FR2338285A1 publication Critical patent/FR2338285A1/fr
Application granted granted Critical
Publication of FR2338285B1 publication Critical patent/FR2338285B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/24Condensed ring systems having three or more rings
    • C07H15/252Naphthacene radicals, e.g. daunomycins, adriamycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
FR7701034A 1976-01-16 1977-01-14 Nouveaux derives de glycosides d'anthracycline et procede pour les preparer Granted FR2338285A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES444380A ES444380A1 (es) 1976-01-16 1976-01-16 Un procedimiento para preparar derivados metalicos antraci- clinicos.

Publications (2)

Publication Number Publication Date
FR2338285A1 FR2338285A1 (fr) 1977-08-12
FR2338285B1 true FR2338285B1 (enExample) 1980-03-14

Family

ID=8470743

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7701034A Granted FR2338285A1 (fr) 1976-01-16 1977-01-14 Nouveaux derives de glycosides d'anthracycline et procede pour les preparer

Country Status (29)

Country Link
US (1) US4138480A (enExample)
JP (1) JPS52111555A (enExample)
AR (1) AR218620A1 (enExample)
AT (1) AT349634B (enExample)
AU (1) AU513698B2 (enExample)
BE (1) BE850438A (enExample)
CA (1) CA1070680A (enExample)
CH (1) CH629219A5 (enExample)
DD (1) DD129452A5 (enExample)
DE (1) DE2701405C2 (enExample)
DK (1) DK11877A (enExample)
EG (1) EG12735A (enExample)
ES (1) ES444380A1 (enExample)
FI (1) FI770115A7 (enExample)
FR (1) FR2338285A1 (enExample)
GB (1) GB1568263A (enExample)
GR (1) GR70696B (enExample)
HU (1) HU177832B (enExample)
IE (1) IE44689B1 (enExample)
IL (1) IL51264A (enExample)
NL (1) NL7700379A (enExample)
NO (1) NO770122L (enExample)
NZ (1) NZ183084A (enExample)
PH (1) PH16582A (enExample)
PL (1) PL108660B1 (enExample)
PT (1) PT66067B (enExample)
SE (1) SE7700398L (enExample)
SU (1) SU886748A3 (enExample)
YU (1) YU5477A (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2959798A (en) * 1958-03-24 1960-11-15 Champlin Oil & Refining Co Pipe line cleaner
US4337335A (en) * 1978-05-18 1982-06-29 Schering Corporation Transition metal salt complexes of polyamino organic compounds
IT1184161B (it) * 1985-03-14 1987-10-22 Franco Conti Derivati del chitosano costituiti da complessi di coordinazione con ioni ferrosi
JPS63310830A (ja) * 1987-06-10 1988-12-19 Meiji Seika Kaisha Ltd 抗レトロウイルス剤
GB9613182D0 (en) * 1996-06-24 1996-08-28 Nycomed Imaging As Method
NL1009226C2 (nl) * 1998-05-20 1999-11-24 Faculteit Geneeskunde Universi Toepassing van een nucleïnezuur-bindend chemotherapeutisch agens, een farmaceutisch preparaat en een geneesmiddelcombinatie.
WO2004087097A2 (en) * 2003-03-31 2004-10-14 Yissum Research Development Company Of The Hebrew University Of Jerusalem Stable liposomes or micelles comprising a sphinolipid and a peg-lipopolymer
US7053191B2 (en) * 2003-05-21 2006-05-30 Solux Corporation Method of preparing 4-R-substituted 4-demethoxydaunorubicin
CA2587470A1 (en) * 2004-11-15 2006-05-18 Yissum Research Development Company Of The Hebrew University Of Jerusale M Combination therapy associating preferably a ceramide with a cytotoxic drug
WO2008100591A2 (en) * 2007-02-14 2008-08-21 The General Hospital Corporation Modulation of nitric oxide signaling to normalize tumor vasculature
DK3012329T3 (da) 2010-06-18 2017-11-20 Myriad Genetics Inc Fremgangsmåder og materialer til at vurdere tab af heterozygositet
ES2588979T3 (es) 2010-08-24 2016-11-08 Dana-Farber Cancer Institute, Inc. Procedimientos para la predicción de una respuesta contra el cáncer
EP2721181B1 (en) 2011-06-17 2019-12-18 Myriad Genetics, Inc. Methods and materials for assessing allelic imbalance
EP4497824A3 (en) 2011-12-21 2025-04-16 Myriad Genetics, Inc. Methods and materials for assessing loss of heterozygosity
AU2013226400B2 (en) 2012-02-23 2018-09-06 Dana-Farber Cancer Institute, Inc. Methods for predicting anti-cancer response
ES2658867T3 (es) 2012-06-07 2018-03-12 Institut Curie Métodos para detectar la inactivación de la ruta de recombinación homóloga (BRCA1/2) en tumores humanos
WO2014160080A1 (en) 2013-03-14 2014-10-02 Children's Medical Center Corporation Cancer diagnosis, treatment selection and treatment
WO2014165785A2 (en) 2013-04-05 2014-10-09 Myriad Genetics, Inc. Methods and materials for assessing homologous recombination deficiency
ES2909899T3 (es) 2013-12-09 2022-05-10 Inst Curie Métodos para detectar inactivación de la ruta de recombinación homóloga (BRCA1/2) en tumores humanos
DK3180447T3 (da) 2014-08-15 2020-06-15 Myriad Genetics Inc Fremgangsmåder og materialer til analyse af homolog rekombinationsdeficiens
EP4141127B1 (en) 2021-08-30 2024-10-09 Zentrum Familiärer Brust- und Eierstockkrebs Universitätsklinik Köln Method for assessing homologous recombination deficiency in ovarian cancer cells

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3074927A (en) * 1960-04-12 1963-01-22 Paul D Saltman Metallic complexes of reducing sugars
YU33730B (en) * 1967-04-18 1978-02-28 Farmaceutici Italia Process for preparing a novel antibiotic substance and salts thereof
GB1469430A (en) * 1974-12-24 1977-04-06 Farmaceutici Italia Daunomycin derivatives

Also Published As

Publication number Publication date
PH16582A (en) 1983-11-22
SU886748A3 (ru) 1981-11-30
JPS52111555A (en) 1977-09-19
IE44689B1 (en) 1982-02-24
NL7700379A (nl) 1977-07-19
GB1568263A (en) 1980-05-29
NZ183084A (en) 1980-04-28
AT349634B (de) 1979-04-10
FI770115A7 (enExample) 1977-07-17
YU5477A (en) 1982-06-30
SE7700398L (sv) 1977-07-17
AU2131977A (en) 1978-07-20
DD129452A5 (de) 1978-01-18
AR218620A1 (es) 1980-06-30
DE2701405C2 (de) 1986-02-27
GR70696B (enExample) 1982-12-30
IL51264A (en) 1980-05-30
CA1070680A (en) 1980-01-29
DK11877A (da) 1977-07-17
ATA19677A (de) 1978-09-15
AU513698B2 (en) 1980-12-18
IE44689L (en) 1977-07-16
US4138480A (en) 1979-02-06
IL51264A0 (en) 1977-03-31
FR2338285A1 (fr) 1977-08-12
PT66067B (en) 1978-06-23
DE2701405A1 (de) 1977-07-21
ES444380A1 (es) 1977-06-16
JPS6133039B2 (enExample) 1986-07-31
PL108660B1 (en) 1980-04-30
CH629219A5 (de) 1982-04-15
NO770122L (no) 1977-07-19
EG12735A (en) 1981-03-31
HU177832B (en) 1981-12-28
PL195344A1 (pl) 1978-08-14
PT66067A (en) 1977-02-01
BE850438A (fr) 1977-05-16

Similar Documents

Publication Publication Date Title
DK140821C (enExample)
FR2350216B1 (enExample)
FR2367478B1 (enExample)
DE2760025A1 (enExample)
FR2362194B1 (enExample)
FR2338285B1 (enExample)
DK128477A (enExample)
JPS5426629B2 (enExample)
DE2747168C3 (enExample)
JPS5297698U (enExample)
JPS5715514B2 (enExample)
JPS5315352U (enExample)
JPS537512U (enExample)
FR2349677B1 (enExample)
JPS5357194U (enExample)
JPS5297613U (enExample)
JPS5365693U (enExample)
DK137113C (enExample)
JPS5444155B2 (enExample)
JPS5344512B2 (enExample)
JPS5353358U (enExample)
JPS5329393U (enExample)
DE7602932U1 (enExample)
JPS5319295U (enExample)
JPS52126777U (enExample)

Legal Events

Date Code Title Description
ST Notification of lapse